http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이질적 환경에서의 layering 되어진 멀티미디어 스트림 서비스
이홍기(Lee Heung-ki),김현정(Kim Hyun-Jung),김상형(Kim Sang-Hyung),김현정(Kim Hyun-Jung),신정아(Shin Jung-Ah),이성인(Lee Sung-In),유관종(Yoo Kawn-Jong) 한국정보과학회 2002 한국정보과학회 학술발표논문집 Vol.29 No.1A
다양한 네트웍 환경에서의 멀티미디어 서비스에 대한 연구가 많이 이루어지고 있다. 그러나, 아직까지 멀티미디어 데이터의 양을 감당할 수 있는 네트웍 환경이 구성되어져 있지 않고 있다. 이러한, 가변적인 네트웍 환경에 적응하면서, 사용자의 욕구를 만족시키기 위한 연구가 활발히 이루어지고 있다. 그 중에서 layering 되어진 멀티미디어 데이터에 대한 연구가 많이 진행 중이다. 이에 본 논문은 이러한 layering data의 전송방법에 대하여 논하고자 한다.
당뇨병 환자에서 고위험 관상동맥 중재술시 혈소판 당단백 IIb / IIIa 수용체 차단제 ( Abciximab : ReoPro ) 의 장기 임상 효과
심두선(Doo Sun Sim),정명호(Myung Ho Jeong),김원(Weon Kim),류제영(Jay Young Rhew),염주협(Ju Hyup Yum),김주한(Ju Han Kim),안영근(Young Keun Ahn),조정관(Jeong Gwan Cho),박종춘(Jong Chun Park),안병희(Byoung Hee Ahn),김상형(Sang Hyung Ki 대한내과학회 2002 대한내과학회지 Vol.62 No.2
Background: High-risk percutaneous coronary interventions (PCI) are associated with high complication rate, low procedural success rate and high restenosis rate, especially in diabetics. We sought to observe whether diabetes affects long-term clinical outcomes after Abciximab (ReoPro) therapy in Korean patients undergoing high-risk PCI. Methods: One hundred nineteen patients with 152 lesion sites were administered ReoPro out of 2,231 patients who underwent PCI at Chonnam National University Hospital from Mar 1999 to Feb 2001. They were divided into two groups, 30 in diabetic group (Group I, 57.7±8.2 years, 22 male) and 89 in non-diabetic group (Group II, 59.6±10.8 years, 68 male). Early and long-term clinical outcomes after PCI were analyzed. Results: In clinical diagnosis the number of acute myocardial infarction was 25 in Group I (83.3%) and 76 in Group II (85.4%). As for risk factors and target lesion artery, ACC/AHA types, there were no differences between the two groups. The number of patients with total occlusion was 21 (55.3%) and 62 (53.9%) and thrombus-containing lesion 28 (93.3%) and 88 (98.9%) in Group I and II respectively. Procedure was successful in 27 (90.0%) in Group I and 80 (89.9%) in Group II and there were no differences in bleeding complications. No major adverse cardiac events (MACE), including myocardial infarction, repeat revascularization or cardiac death were observed in Group I, but there were 8 cases of MACE in Group II during hospitalization. Clinical follow-up was performed in 116 patients (97.5%) during 18.5±6.7 (5∼28) months. The number of overall MACEs were 10 (3.3%) in Group I and 14 (15.7%) in Group II (p=0.038). Conclusion: ReoPro used in high-risk PCI in diabetics was effective in early clinical outcome, but long-term clinical benefits were not warranted.(Korean J Med 62:171-181, 2002)